Shares of Tesaro Inc (TSRO) have recently traded to new all time highs and are now sitting at $29.40 The shares have now more than doubled since coming public at $13.50 in June of 2012. However, a series of near term challenges to its lead drug candidate could see the shares drop back below $21.00…
Shares of Ziopharm Oncology (ZIOP) plunged by 64% to $1.82 on Tuesday when it released news that its only late stage drug candidate failed to meet its primary endpoint. For now, there isn’t much of a play except for those who may wish to bet on some further downside. No one can truly predict…
Disclosure: I am short ALNY. The past 12-14 months have seen a very strong rally in the overall markets, sending the Nasdaq index to levels not seen in 13 years. Biotech stocks have largely been leading the pack and have provided spectacular returns to those who have been chasing the ultra-high beta returns. Since the beginning of 2012,…
A close investigation of Ziopharm (ZIOP) reveals an undisclosed FDA warning letter and instability with Palifosfamide
